Division of Solid Tumor Oncology
The Solid Tumor Division is composed of a group of dedicated physicians that have developed disease-oriented subspecialty programs in solid tumor cancers. These physicians work closely with their surgical and radiation oncology colleagues in a multi-disciplinary setting to deliver integrative care with cutting edge research. The director of the division is Wm. Kevin Kelly, DO is known nationally and internationally for developing novel therapeutics for prostate cancer and other malignancies and an expert in clinical trials design and implementation. He previously served as the co-director of the Genitourinary Oncology Program and Associate Director of the Clinical Research Services in the Yale Comprehensive Cancer Center prior to joining the faculty at Thomas Jefferson University. A summary of the division's programs are listed below.
- Brain Tumor Program
- Early Drug/ Development/ Phase I Program
- Gastrointestinal Oncology Program
- Genitourinary Program
- Melanoma Program
- Respiratory Tract Malignancies Program
- Women’s Oncologic Health (Breast and Gynecologic Malignancies) Program
There has been a rapid expansion of the Solid Tumor Oncology faculty and this growth is on track to continue through the next academic year. This growth has been accompanied by an influx of new patients and exciting new ideas.